English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 16 July 2014, 09:55 HKT/SGT
Share:
    

Source: INC Research, LLC
INC Research, LLC Second Quarter 2014 Results of Operations Release Date and Conference Call

Raleigh, N.C., July 16, 2014 - (ACN Newswire) - INC Research, LLC (the "Company"), a leading, global Phase I to Phase IV clinical research organization (CRO), will conduct a conference call to discuss its second quarter 2014 financial results at 10:00 a.m. ET on Wednesday, August 13, 2014. The second quarter financial results will be available on the Company's secure website no later than Tuesday, August 12, 2014. Further details about the call will be provided at a later date.

To access the financial results and dial-in information for the conference call, a party must pre-register and certify that it is eligible to do so. Access to the financial results and conference call will be available only to (1) holders of the Company's 11.5% Senior Notes due 2019, (2) hi-yield securities analysts and broker-dealers and (3) prospective investors that certify that they are qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended. To receive information on how to pre-register and certify eligibility, parties must send an email to thomas.zajkowski@incresearch.com requesting access to the financial results and conference call information no later than Friday, August 8, 2014.

About INC Research

INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the world's biopharmaceutical and medical device industry. As a therapeutically focused CRO, with a Trusted Process(R) delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research

LinkedIn: https://www.linkedin.com/company/11776
Twitter: @inc_research

Contact:
INC Research, LLC
Thomas E. Zajkowski, VP & Treasurer, +1-919-257-6601

###

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: INC RESEARCH, LLC via Globenewswire

Topic: General Announcement
Source: INC Research, LLC


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

INC Research, LLC Related News
Nov 7, 2014 08:50 HKT/SGT
INC Research Announces Pricing of Initial Public Offering
Oct 7, 2014 07:10 HKT/SGT
INC Research Files Registration Statement for Initial Public Offering
Oct 3, 2014 10:30 HKT/SGT
INC Research Demonstrates Continued Dedication to Site Relationships at 2014 SCRS Site Solutions Summit
Oct 2, 2014 07:20 HKT/SGT
INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role
Aug 6, 2014 03:30 HKT/SGT
INC Research's Tara Fitzgerald and Judy Swilley Named to Annual PharmaVOICE 100
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575